The therapy of multiple sclerosis with immune-modulating or immunosuppressive drug-Reference-Cited by-同舟云学术

The therapy of multiple sclerosis with immune-modulating or immunosuppressive drug

Published:2008-11 Issue:9 Volume:110 Page:878-885
ISSN:0303-8467
Container-title:Clinical Neurology and Neurosurgery
language:en
Short-container-title:Clinical Neurology and Neurosurgery

Author:

Clerico Marinella,Rivoiro Chiara,Contessa Giulia,Viglietti Daniela,Durelli Luca

Publisher

Elsevier BV

Subject

Clinical Neurology,General Medicine,Surgery

Reference30 articles.

1. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial;Neurology,1993

2. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG);Jacobs;Ann Neurol,1996

3. Randomised, double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group. Lancet 1998;352:1498–504.

4. CONSORT GROUP (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: explanation and elaboration;Altman;Ann Intern Med,2001

5. Interferons in relapsing remitting multiple sclerosis: a systematic review;Filippini;Lancet,2003

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brief electrical nerve stimulation enhances intrinsic repair capacity of the focally demyelinated central nervous system;Neural Regeneration Research;2022

2. A panoramic view of chronic liver diseases and natural remedies reported in Traditional Persian Medicine;Current Pharmaceutical Design;2015-12-21

3. Delayed Nerve Stimulation Promotes Axon-Protective Neurofilament Phosphorylation, Accelerates Immune Cell Clearance and Enhances Remyelination In Vivo in Focally Demyelinated Nerves;PLoS ONE;2014-10-13

4. Extracellular adenosine signaling induces CX3CL1 expression in the brain to promote experimental autoimmune encephalomyelitis;Journal of Neuroinflammation;2012-08-10

5. Gold Standard Animal Models;Pharmaceutical Sciences Encyclopedia;2011-12-16